Zusammenfassung
Bei der Darstellung von Bewegungsstörungen im Rahmen der Multiplen Sklerose muss man zunächst festlegen, welche motorischen Phänomene in diesem Zusammenhang als Bewegungsstörungen angesehen werden sollen. Die folgende Übersicht zeigt den Versuch einer Klassifikation der Bewegungsstörungen. Danach können Bewegungsstörungen eingeteilt werden in hypokinetische Formen, bei denen es zu einer verminderten Muskelaktivität kommt, in hyperkinetische Formen, bei denen eine gesteigerte Muskelaktivität auftritt, und in gemischte Formen, bei denen gleichzeitig eine verminderte und eine gesteigerte Muskelaktivität zu beobachten ist. Die wichtigsten hypokinetischen Bewegungsstörungen sind Bradykinese und Hypokinese, die bis zu akinetischen Krisen und zum Freezing führen können. Katatonie, Kataplexie, apraktische Störungen, kallosale Bewegungsstörungen und Fatigue werden klassischerweise nicht als hypokinetische Bewegungsstörungen angesehen, obwohl es auch hier zu einer Verminderung von Muskelaktivitäten kommt. Zu den hyperkinetischen Bewegungsstörungen werden Dystonie, Chorea, Athetose, Ballismus, Tremor, Myoklonus, Tics, Stereotypien, Akathisie, Restless-Legs-Syndrom, Myokymie und Myorhythmie gezählt. Spastik, Spasmen, Rigor, Hyperekplexie, Stiff-Person-Syndrom, Ataxie, Synkinesien und Spasmus hemifacialis werden klassischerweise nicht als hyperkinetische Bewegungsstörungen aufgefasst, obwohl auch hier Muskelüberaktivitäten auftreten.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Ada L, Canning C (1990) Anticipating and avoiding muscle shortening. In: Ada L, Canning C (eds) Key issuses in neurological physiotherapy. In: Carr JH, Shepherd RB (eds) Phy-siotherapy: Foundations for Practice. Butterworth-Heinemann, Oxford
Aisen ML, Arnold A, Baiges I, Maxwell S, Rosen M (1993) The effect of mechanical damping loads on disabling action tremor. Neurol 43:1346–1350
Andrew J (1984) Surgical treatment of tremor. In: Findley LJ, Capildeo R (eds) Movement disorders: Tremor. Macmillan, London, pp 339–351
Bakshi R, Shaikh ZA, Miletich RS, Czarnecki D, Dmochowski J, Henschel K, Janardhan V, Dubey N, Kinkel PR (2000) Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler 6:181–185 Berard C, Sindou M, Berard J, Carrier H (1988) Selective neurotomy of the tibial nerve in the spastic hemiplegie child: An explanation of the recurrence. J Pediatr Orthop B 7:66–70
Berard C, Sindou M, Berard J, Carrier H (1988) Selective neurotomy of the tibial nerve in the spastic hemiplegic child: An explanation of the recurrence. J Pediatr Orthop B 7:66–70
Caparros-Lefebvre D, Pollak P, Feltin MP, Blond S, Benabid AL (1999) The effect of thalamic stimulation on levodopa induced dyskinesias-evaluation of a new target: the center para- fascicular median. Rev Neurol (Paris) 155:543–550
Cardoso F, Jankovic J, Grossman RG, Hamilton WJ (1995) Outcome after stereotactic thalamotomy for dystonia and hemiballismus. Neurosurg 36:501–508
Chaudhuri A, Watson WS, Pearn J, Behan PO (2000) The symptoms of chronic fatigue syndrome are related to abnormal ion channel function. Med Hypotheses 54:59–63
Consroe P, Musty R, Rein J, Tillery W, Pertwee R (1997) The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol 38:44–48
De Silva KL, Pearce J (1972) Facial myokymia: a clue to the diagnosis of multiple sclerosis. Postgrad Med J 48:657–662
Deuschl G, Bain P, Brin M (1998) Consensus statement of the movement disorder society on tremor. Mov Disord 13 (Suppl 3):2–23
Diener HC, Dichgans J (1992) Pathophysiology of cerebellar ataxia. Mov Disord 7:95–109
Dressler D (2000) Botulinum Toxin Therapy. Thieme, Stuttgart, New York
Ekbom KA, Westerberg CE, Osterman PO (1968) Focal sensory-motor seizures of spinal origin. Lancet 1:67
Fahn S (1984) Cerebellar tremor: Clinical aspects. In: Findley LJ, Capildeo R (eds) Movement disorders: Tremor. Macmillan, London, pp 355–364
Fahn S, Marsden CD, Calne DB (1987) Classification and investigation of dystonia. In: Marsden CD, Fahn S (eds) Movement disorders 2. Butterworths, London, pp 332–358
Fasano VA, Broggi G, Zeme S (1988) Intraoperative electrical stimulation for functional posterior rhizotomy. Scand J Rehabil Med Suppl 17:149–154
Geisler MW, Sliwinski M, Coyle PK, Masur DM, Doscher C, Krupp LB (1996) The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis. Arch Neurol 53:185–188
Goetz CG, Bakdash T (1999) Acquired paroxysmal dyskinesias. In: Joseph AB, Young RR (eds) Movement disorders in neurology and neuropsychiatry, 2nd edn. Blackwell Science, Maiden, pp 509–516
Gracies JM, Nance P; Elovic E, McGuire J, Simpson DM (1997) Traditional pharmacological treatments for spasticity part 1: Local treatments. In: Brin MF (ed) Spasticity: etiology, evaluation, management, and the role of botulinum toxin type A. Muscle Nerve 20 (Suppl 6):61–91
Gutmann L, Hopf HC, Gutierrez A, Burton V (1993) Intrapontine generation of myokymia in multiple sclerosis. Muscle Nerve 16:981–982
Hallett M, Ravits J, Dubinsky RM, Gillespie MM, Moinfar A (1991) A double-blind trial of isoniazid for essential tremor and other action tremors. Mov Disord 6:253–256
Heath PD, Nightingale S (1982) Clusters of tonic spasms as an initial manifestation of multiple sclerosis. Ann Neurol 5:494–495
Jacobs L, Kaba S, Pullicino P (1994) The lesion causing continuous facial myokymia in multiple sclerosis. Arch Neurol 51:1115–1119
Jankovic J, Cardoso F, Grossman RG, Hamilton WJ (1995) Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. Neurosurg 37:680–687
Kesselring J, Thompson AJ (1997) Spasticity, ataxia and fatigue in multiple sclerosis. Baillieres Clin Neurol 6:429–445
Lance JW (1980) Symposium synopsis. In: Feldman RG, Young RR, Koella WP (eds) Spasticity: disordered motor control. Year Book Medical Publishers, Chicago
Latash M, Kalugina E, Nicholas J, Orpett C, Stefoski D, Davis F (1996) Myogenic and central neurogenic factors in fatigue in multiple sclerosis. Mult Scler 1:236–241
Leshin N, Stone T (1931) Continuous rhythmic movements of the palate, pharynx and larynx. Arch Neurol Psychiat 26:1236–1250
Loher TJ, Hasdemir MG, Burgunder JM, Krauss JK (2000) Long-term follow-up study of chronic globus pallidus internus stimulation for posttraumatic hemidystonia. J Neurosurg 92:457–460
Lou JS, Jankovic J (1991) Tremors. In: Appel SH (ed) Current neurology, vol 11. Mosby Year Book, Chicago, pp 199–232
Matthews WB (1958) Tonic seizures in disseminated sclerosis. Brain 81:193–206
Meinck HM, Schonle PW, Conrad B (1989) Effect of cannabinoids on spasticity and ataxia in multiple sclerosis. J Neurol 236:120–122
Münchau A, Palmer JD, Dressler D, O’Sullivan J, Tsang KL, Jahanshahi M, Quinn N, Lees AJ, Bhatia KP (2000) Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia. Mov Disord 15 (Suppl 3): 141
Myers E (1965) Ballismus. In: Vinken PJ, Bruyn GW (eds) Handbook of neurology, vol 6. North Holland Publishing, Amsterdam, pp 476–479
Nathanson M (1956) Palatal myoclonus: Further clinical and pathophysiological observations. Arch Neurol Psychiat 75:285–296
Ochs G, Struppler A, Meyerson BA, Linderoth B, Gybels J, Gardner BP, Teddy P, Jamous A, Weinmann P (1989) Intrathecal baclofen for long-term treatment of spasticity: A multi-centre study. J Neurol Neurosurg Psychiat 52:933–939
Ondo WG, Desaloms JM, Jankovic J, Grossman RG (1998) Pallidotomy for generalized dystonia. Mov Disord 13:693–698
Osterman PO, Westerberg CE (1975) Paroxysmal attacks in multiple sclerosis. Brain 98:189–202
Poser S (1984) Klinik der Multiplen Sklerose. Nervenheilkunde 3:53–58
Radu EW, Skorpil V, Kaeser HE (1975) Facial myokymia. Eur Neurol 13:499–512
Remy P, de Recondo A, Defer G, Loc’h C, Amarenco P, Plante-Bordeneuve V, Dao-Castellana MH, Bendriem B, Crouzel C, Clanet M et al. (1995) Peduncular ’rubral’ tremor and dopaminergic denervation: A PET study. Neurol 45:472–477
Sabra AF, Hallett M (1984) Action tremor with alternating activity in antagonist muscles. Neurol 34:151–156
Schnider A, Benson F, Rosner LJ (1993) Callosal disconnection in multiple sclerosis. Neurol 43:1243–1245
Schnider A, Mattle H, Mumenthaler M (1987) Buccolinguofacial apraxia — a probably psy-chogenic speech and deglutition disorder. Schweiz Med Wochenschr 117:1888–1895
Sechi GP, Pirisi A, Agnetti V, Piredda M, Zuddas M, Tanca S, Piras ML, Aiello I, Deserra F, Rosati G (1989) Efficacy of carbamazepine on cerebellar tremors in patients with superior cerebellar artery syndrome. J Neurol 236:461–463
Sedano MJ, Trejo JM, Macarron JL, Polo JM, Berciano J, Calleja J (2000) Continuous facial myokymia in multiple sclerosis: treatment with botulinum toxin. Eur Neurol 43:137–140
Sharma RR, Mathad NV, Joshi DN, Mazarelo TB, Vaidya MM (1992) Persistent facial myoky-mia: a rare pathognomic physical sign of intrinsic brain-stem lesions: report of 2 cases and review of literature. J Postgrad Med 38:37–40 Shibasaki H, Kuroiwa Y (1974) Painful tonic seizure in multiple sclerosis. Arch Neurol 30:47–51
Shibasaki H, Kuriowa Y (1974) Painful tonic seizure in multiple sclerosis. Arch Neurol 30:47–54
Spiller WG (1927) Subcortical epilepsy. Brain 50:171–187
Tenser RB (1976) Myokymia and facial contraction in multiple sclerosis. Arch Intern Med 136:81–83
Tranchant C, Bhatia KP, Marsden CD (1995) Movement disorders in multiple sclerosis. Mov Disord 10:418–423
Trelles L, Trelles JO, Castro C, Altamirano J, Benzaquen M (1984) Successful treatment of two cases of intention tremor with clonazepam. Ann Neurol 16:621
Twomey JA, Espir MLE (1980) Paroxysmal symptoms as the first manifestations of multiple sclerosis. J Neurol Neurosurg Psychiat 43:296–304
Vercoulen JH, Swanink CM, Galama JM, Fennis JF, Jongen PJ, Hommes OR, van der Meer JW, Bleijenberg G (1998) The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. J Psychosom Res 45:507–517
Vidailhet M, Jedynak CP, Pollak P, Agid Y (1998) Pathology of symptomatic tremors. Mov Disord 13 (Suppl 3):49–54
Von Widdern OC, Benecke R, Zettl UK (2000) The effect of ondansetron (tetrahydro- methyl-carbazol-hydrochloride-dihydrate), a 5-HT3 antagonist, on intention tremor in multiple sclerosis. Neurology 54 (Suppl 3):A60
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Dressler, D., Benecke, R., Zettl, U.K. (2001). Bewegungsstörungen bei Multipler Sklerose. In: Zettl, U.K., Mix, E. (eds) Multiple Sklerose. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59453-3_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-59453-3_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-41121-5
Online ISBN: 978-3-642-59453-3
eBook Packages: Springer Book Archive